| ID: 127404188 | OCT4-NANOG-H3K4me1 hESC enhancer GRCh37_chr5:144858933-144859433 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (145479370..145479870) | | |
| ID: 127404187 | NANOG hESC enhancer GRCh37_chr5:144851246-144851794 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (145471683..145472231) | | |
| ID: 127404186 | NANOG hESC enhancer GRCh37_chr5:144613102-144613603 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (145233539..145234040) | | |
| ID: 126807539 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr5:144966712-144967911 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (145587149..145588348) | | |
| ID: 126807538 | CDK7 strongly-dependent group 2 enhancer GRCh37_chr5:144157357-144158556 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (144777794..144778993) | | |
| ID: 116158525 | CRISPRi-validated cis-regulatory element chr5.3602 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (145854558..145855157) | | |
| ID: 105378211 | uncharacterized LOC105378211 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (145429867..145479925) | | |
| ID: 100132712 | nicotinamide phosphoribosyltransferase pseudogene 2 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (145002238..145005801, complement) | | |
| ID: 650866 | TRPC6 pseudogene 2 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (145729005..145729310, complement) | | |
| ID: 643226 | glutaredoxin and cysteine rich domain containing 2 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (145857670..145931673, complement) | DFNB101 | 615762 |
| ID: 153768 | PRELI domain containing 2 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (145228985..145835342, complement) | | 620750 |
| ID: 455 | argininosuccinate synthetase 1 pseudogene 10 [Homo sapiens (human)] | Chromosome 5, NC_000005.10 (145228711..145230285) | ASSP10 | |